pirfenidone has been researched along with Angiogenesis, Pathologic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Calik, E; Guvenal, T; Hasdemir, PS; Koltan, SO; Koyuncu, FM; Ozbilgin, K; Ozkut, M; Uner, MA | 1 |
| Allen, J; Baran, CP; Bhatt, N; Magro, C; Marsh, CB | 1 |
1 review(s) available for pirfenidone and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Promising pharmacologic innovations in treating pulmonary fibrosis.
Topics: Angiogenesis Inhibitors; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antioxidants; Connective Tissue Growth Factor; Humans; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; Lung; Molybdenum; Neovascularization, Pathologic; Pulmonary Fibrosis; Pyridones; Randomized Controlled Trials as Topic | 2006 |
1 other study(ies) available for pirfenidone and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Effect of Pirfenidone on Vascular Proliferation, Inflammation and Fibrosis in an Abdominal Adhesion Rat Model.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Disease Models, Animal; Female; Inflammation; Injections, Intraperitoneal; Interleukin-17; Neovascularization, Pathologic; Peritoneum; Postoperative Complications; Pyridones; Rats; Rats, Wistar; Tissue Adhesions; Transforming Growth Factor beta; Treatment Outcome; Uterus | 2017 |